BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age. (2022)
Attributed to:
Respiratory infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2205011
PubMed Identifier: 35767475
Publication URI: http://europepmc.org/abstract/MED/35767475
Type: Journal Article/Review
Volume: 387
Parent Publication: The New England journal of medicine
Issue: 3
ISSN: 0028-4793